Wednesday, February 10, 2010, 11:57AM AEST - The Australian Stockmarket closes in 4 hours and 8 minutes.
To create a watchlist or portfolio of shares, Register

Bristol-Myers Squibb Co. (BMY)

 8:00AM AEST: 24.25 USD  Up 0.29 (1.21%)  
 MORE ON BMY 
Quotes
HereSummary
Charts
Technical Analysis
News & Info
Company
Analyst Coverage
Ownership
Financials
 BRISTOL-MYERS SQUIBB (NYSE:BMY) Delayed quote dataEdit
Last Trade:24.25 USD
Trade Time: 8:00AM AEST
Change:Up 0.29 (1.21%)
Prev Close:23.96
Open:24.10
Bid:N/A
Ask:N/A
1y Target Est:24.99
Day's Range:23.90 - 24.41
52wk Range:17.23 - 26.62
Volume:9,906,506
Avg Vol (3m):26,002,100
Market Cap:48.04B
P/E (ttm):12.55
EPS (ttm):1.93
Div & Yield:1.25 (5.22%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
 Add BMY to Portfolio   Download Data

 HEADLINES 
•Researchers find sex-specific lung cancer genes
at Reuters (Wed 11:34AM)
•How Much Should Cancer Drugs Cost?
at The Wall Street Journal Online (Wed 8:05AM)
•Make Thousands From Millions
at Motley Fool (Wed 5:20AM)
•UPDATE - U.S. FDA staff questions small ChemGenex study
at Reuters (Tue 11:57AM)
•UK says Novartis, Bristol cancer drugs too costly
at Reuters (Tue 11:01AM)
•Monday Options Recap: Volatility Eases
at Seeking Alpha (Tue 7:55AM)
•Correction is Healthy - and a Buying Opportunity: Strategist
at CNBC (Tue 3:55AM)
•AMRI reports $19M net loss in 4Q
at bizjournals.com (Tue 2:05AM)
•UPDATE - U.S. FDA staff questions small ChemGenex study
at Reuters (Tue 1:25AM)
•How Big Pharma Got in This Fix
at Seeking Alpha (Mon, Feb 8)
•Bristol-Myers Squibb to freeze salaries in 2010
AP (Sat, Feb 6)
•Stalled Health Care Bill Leaves Drug Makers in Regulatory Limbo
at The New York Times (Sat, Feb 6)
•Why Pharma's Patent Cliff Is Good News for Pharmacies
at The Wall Street Journal Online (Sat, Feb 6)
•[$$] Cost Cutting Boosts Profits
at The Wall Street Journal Online (Fri, Feb 5)
More Headlines for BMY...
 ANALYST 
EPS Est (next year) (Dec-09) :1.78
EPS Est (in 2 years) (Dec-10) :2.21
Avg Rec (current)*:2.6
PEG Ratio:5.21
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Bristol-Myers Squibb Company (BMS) engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of pharmaceuticals and nutritional products worldwide.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
•Latest News•7 Indices